Bohai Pharmaceuticals Group Inc (BOPH) financial statements (2023 and earlier)

Company profile

Business Address C/O YANTAI BOHAI PHARMACEUTICALS GROUP
YANTAI, SHANDONG PROVINCE, 264000
State of Incorp. NV
Fiscal Year End June 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

6/30/2014
6/30/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments23,3096,948
Cash and cash equivalents23,3096,948
Restricted cash and investments12,623 
Receivables 38,716
Inventory, net of allowances, customer advances and progress billings4,5012,782
Inventory4,5012,782
Other undisclosed current assets42,18613,073
Total current assets:82,61961,519
Noncurrent Assets
Inventory, Noncurrent4,501 
Property, plant and equipment21,12817,678
Intangible assets, net (including goodwill)80,74457,175
Goodwill5,2235,202
Intangible assets, net (excluding goodwill)75,52151,973
Deferred tax assets, net8,144 
Other undisclosed noncurrent assets(12,369)29,252
Total noncurrent assets:102,148104,105
TOTAL ASSETS:184,766165,624
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities21,63319,490
Accounts payable 5,082
Accrued liabilities15,71912,186
Employee-related liabilities456 
Taxes payable3,0862,222
Interest and dividends payable2,373 
Debt4,8738,465
Other undisclosed current liabilities13,08016,232
Total current liabilities:39,58644,187
Noncurrent Liabilities
Liabilities, other than long-term debt 8,048
Deferred tax liabilities, net 8,048
Other undisclosed noncurrent liabilities15,5805,000
Total noncurrent liabilities:15,58013,048
Total liabilities:55,16657,235
Stockholders' equity
Stockholders' equity attributable to parent129,601108,390
Common stock1818
Additional paid in capital24,82224,615
Accumulated other comprehensive income8,1149,000
Retained earnings96,64674,757
Total stockholders' equity:129,601108,390
TOTAL LIABILITIES AND EQUITY:184,766165,624

Income statement (P&L) ($ in thousands)

6/30/2014
6/30/2013
Revenues175,086151,793
Revenue, net 151,793
Cost of revenue(42,376)(38,208)
Cost of goods and services sold (38,208)
Other undisclosed gross profit 1,011
Gross profit:132,710114,596
Operating expenses(100,299)(87,718)
Operating income:32,41126,878
Nonoperating income (expense)545(734)
Investment income, nonoperating18439
Foreign currency transaction loss, before tax(885) 
Other nonoperating income (expense)1,247(17)
Interest and debt expense2,287(1,968)
Income from continuing operations before equity method investments, income taxes:35,24324,176
Other undisclosed income (loss) from continuing operations before income taxes(3,688)1,968
Income from continuing operations before income taxes:31,55526,144
Income tax expense (benefit)9,666(7,020)
Net income:41,22119,124
Other undisclosed net loss attributable to parent(19,332) 
Net income available to common stockholders, basic:21,88919,124
Other undisclosed net income available to common stockholders, diluted5831,069
Net income available to common stockholders, diluted:22,47220,193

Comprehensive Income ($ in thousands)

6/30/2014
6/30/2013
Net income:41,22119,124
Comprehensive income:41,22119,124
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(20,218)2,764
Comprehensive income, net of tax, attributable to parent:21,00421,887

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: